Name: Engineering ExosomeAntibody Conjugates (en Inglés)
SKU: 66360525
Price: 88.45 USD
Availability: InStock
Author: Mosaddeghi Heris, Reza; Aghazadeh, Hamed; Bagheri, Kimia
ISBN: 9786209259630

portada Engineering ExosomeAntibody Conjugates (en Inglés)

Engineering ExosomeAntibody Conjugates (en Inglés)

Formato

Libro Físico

Editorial

LAP Lambert Academic Publishing

Autor

Mosaddeghi Heris, Reza; Aghazadeh, Hamed; Bagheri, Kimia

Idioma

Inglés

N° páginas

136

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x0.8 cm

ISBN13

9786209259630

Engineering ExosomeAntibody Conjugates (en Inglés)

Mosaddeghi Heris, Reza; Aghazadeh, Hamed; Bagheri, Kimia (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 25 a 32 días háb.

$ 160.82$ 88.45

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 88.45

Llega entre el 20 Oct y el 04 Nov a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Engineering ExosomeAntibody Conjugates (en Inglés)"

This book explores the emerging field of engineered exosome-antibody conjugates as an innovative platform for overcoming the long-standing challenge of limited drug delivery across the blood-brain barrier. It examines how surface-modification strategies-such as ligand functionalization, membrane engineering, targeted antibodies, and nanoscale optimization-can enhance cellular uptake and improve neurological specificity. The text highlights recent advances in exosome biogenesis control, loading technologies, and conjugation chemistries that increase therapeutic precision while minimizing off-target effects. Special attention is given to translational pathways, including preclinical validation, pharmacokinetic profiling, safety requirements, and regulatory considerations for moving these hybrid biotherapeutics toward clinical application. The book positions exosome-antibody systems as a promising next-generation solution for treating complex brain disorders with higher efficiency and reduced systemic toxicity.